46. Malignant rheumatoid arthritis Clinical trials / Disease details
Clinical trials : 4,325 / Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR-TRC-08000093 | 2004-09-01 | 2008-04-28 | Phase ?clinical trial of chicken type II collagen in rheumatoid arthritis | Phase ?clinical trial of chicken type II collagen in rheumatoid arthritis | Rheumatoid arthritis | MTX group:MTX (10 mg/week) is applied in the treatment of ac;CII group:MTX (10 mg/week) is applied in the treatment of ac; | Shanghai Materia Medica Bioengineering Institute | NULL | Completed | 18 | 65 | Both | MTX group:160;CII group:300; | 3 (Phase 3 study) | China |
| 2 | NCT00001614 (ClinicalTrials.gov) | July 1997 | 3/11/1999 | The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis | The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis | Arthritis, Juvenile Rheumatoid;Uveitis | Drug: Chicken type II collagen | National Eye Institute (NEI) | NULL | Completed | N/A | N/A | Both | 13 | Phase 1 | United States |